Kcm Investment Advisors LLC Bristol Myers Squibb CO Transaction History

Kcm Investment Advisors LLC

$2.68 Billion
Q1 2024

A detailed history of Kcm Investment Advisors LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Kcm Investment Advisors LLC holds 25,353 shares of BMY stock, worth $1.01 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

25,353

Previous 52,034 51.28%

Holding current value

$1.01 Million

Previous $2.67 Million 48.52%

% of portfolio

0.05%

Previous 0.11%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	SELL	$47.98 - $54.4 $1.28 Million - $1.45 Million	-26,681 Reduced 51.28%	25,353 $1.37 Million
Q4 2023 Feb 13, 2024	SELL	$48.48 - $57.85 $668,248 - $797,404	-13,784 Reduced 20.94%	52,034 $2.67 Million
Q3 2023 Nov 08, 2023	SELL	$57.89 - $64.73 $156,303 - $174,771	-2,700 Reduced 3.94%	65,818 $3.82 Million
Q2 2023 Aug 09, 2023	SELL	$63.71 - $70.74 $1.32 Million - $1.46 Million	-20,656 Reduced 23.16%	68,518 $4.38 Million
Q1 2023 May 09, 2023	BUY	$65.71 - $74.53 $553,343 - $627,617	8,421 Added 10.43%	89,174 $6.18 Million

Q4 2022 Jan 31, 2023	SELL	$68.48 - $81.09 $157,504 - $186,507	-2,300 Reduced 2.77%	80,753 $5.81 Million
Q3 2022 Nov 10, 2022	SELL	$0.13 - $76.84 $22 - $13,139	-171 Reduced 0.21%	83,053 $5.9 Million
Q2 2022 Aug 15, 2022	SELL	$72.62 - $79.98 $319,600 - $351,991	-4,401 Reduced 5.02%	83,224 $6.41 Million
Q1 2022 May 13, 2022	SELL	$61.48 - $73.72 $181,857 - $218,063	-2,958 Reduced 3.27%	87,625 $6.4 Million
Q4 2021 Feb 14, 2022	SELL	$53.63 - $62.52 $251,095 - $292,718	-4,682 Reduced 4.91%	90,583 $5.65 Million
Q3 2021 Nov 12, 2021	SELL	$59.17 - $69.31 $54,732 - $64,111	-925 Reduced 0.96%	95,265 $5.64 Million
Q2 2021 Oct 21, 2021	SELL	$61.91 - $67.42 $513,853 - $559,586	-8,300 Reduced 7.94%	96,190 $6.43 Million
Q2 2021 Aug 12, 2021	SELL	$61.91 - $67.42 $74,849 - $81,510	-1,209 Reduced 1.14%	104,490 $6.98 Million
Q1 2021 May 13, 2021	SELL	$59.34 - $66.74 $177,189 - $199,285	-2,986 Reduced 2.75%	105,699 $6.67 Million
Q4 2020 Feb 19, 2021	SELL	$57.74 - $65.43 $244,990 - $277,619	-4,243 Reduced 3.76%	108,685 $6.74 Million
Q3 2020 Nov 16, 2020	SELL	$57.43 - $63.64 $738,951 - $818,855	-12,867 Reduced 10.23%	112,928 $6.81 Million
Q2 2020 Aug 14, 2020	BUY	$54.82 - $64.09 $415,809 - $486,122	7,585 Added 6.42%	125,795 $7.4 Million
Q1 2020 Apr 27, 2020	SELL	$46.4 - $67.43 $306,008 - $444,700	-6,595 Reduced 5.28%	118,210 $6.59 Million
Q4 2019 Feb 18, 2020	SELL	$49.21 - $64.19 $451,550 - $589,007	-9,176 Reduced 6.85%	124,805 $8.01 Million
Q3 2019 Nov 15, 2019	SELL	$42.77 - $50.71 $949,536 - $1.13 Million	-22,201 Reduced 14.21%	133,981 $6.79 Million
Q2 2019 Aug 14, 2019	SELL	$44.62 - $49.34 $529,282 - $585,271	-11,862 Reduced 7.06%	156,182 $7.08 Million
Q1 2019 May 16, 2019	SELL	$45.12 - $53.8 $430,805 - $513,682	-9,548 Reduced 5.38%	168,044 $8.02 Million
Q4 2018 Feb 12, 2019	SELL	$48.76 - $63.23 $302,945 - $392,847	-6,213 Reduced 3.38%	177,592 $9.23 Million
Q3 2018 Nov 07, 2018	SELL	$55.19 - $62.25 $450,515 - $508,146	-8,163 Reduced 4.25%	183,805 $0
Q2 2018 Aug 10, 2018	SELL	$50.53 - $62.98 $4.27 Million - $5.32 Million	-84,456 Reduced 30.55%	191,968 $10.6 Million
Q1 2018 May 09, 2018	SELL	$59.92 - $68.98 $366,770 - $422,226	-6,121 Reduced 2.17%	276,424 $17.5 Million
Q4 2017 Feb 22, 2018	SELL	$59.94 - $65.35 $592,806 - $646,311	-9,890 Reduced 3.38%	282,545 $17.3 Million
Q3 2017 Nov 13, 2017	BUY	$55.23 - $63.74 $16.2 Million - $18.6 Million	292,435	292,435 $18.6 Million

Others Institutions Holding BMY

# of Institutions

2,553

Shares Held

1.49B

Call Options Held

25.9M

Put Options Held

20M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $84.3B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kcm Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kcm Investment Advisors LLC with notifications on news.

Account

Kcm Investment Advisors LLC Bristol Myers Squibb CO Transaction History